These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20351769)

  • 1. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights.
    Goto Y; Li B; Claesen J; Shi Y; Bibb MJ; van der Donk WA
    PLoS Biol; 2010 Mar; 8(3):e1000339. PubMed ID: 20351769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the evolution of lanthipeptide biosynthesis.
    Yu Y; Zhang Q; van der Donk WA
    Protein Sci; 2013 Nov; 22(11):1478-89. PubMed ID: 24038659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Analysis of Class I Lanthipeptides from
    Bothwell IR; Caetano T; Sarksian R; Mendo S; van der Donk WA
    ACS Chem Biol; 2021 Jun; 16(6):1019-1029. PubMed ID: 34085816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
    Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
    Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic studies of Ser/Thr dehydration catalyzed by a member of the LanL lanthionine synthetase family.
    Goto Y; Okesli A; van der Donk WA
    Biochemistry; 2011 Feb; 50(5):891-8. PubMed ID: 21229987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 21. In vitro studies of lantibiotic biosynthesis.
    Li B; Cooper LE; van der Donk WA
    Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases.
    Zhang X; van der Donk WA
    Methods Enzymol; 2009; 462():117-34. PubMed ID: 19632472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide search for eliminylating domains reveals novel function for BLES03-like proteins.
    Khater S; Mohanty D
    Genome Biol Evol; 2014 Jul; 6(8):2017-33. PubMed ID: 25062915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Studies on Dehydration in Class V Lanthipeptides.
    Liang H; Lopez IJ; Sánchez-Hidalgo M; Genilloud O; van der Donk WA
    ACS Chem Biol; 2022 Sep; 17(9):2519-2527. PubMed ID: 36044589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of lanthipeptide synthetases.
    Zhang Q; Yu Y; Vélasquez JE; van der Donk WA
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18361-6. PubMed ID: 23071302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.
    McClerren AL; Cooper LE; Quan C; Thomas PM; Kelleher NL; van der Donk WA
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17243-8. PubMed ID: 17085596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Michael-type cyclizations in lantibiotic biosynthesis are reversible.
    Yang X; van der Donk WA
    ACS Chem Biol; 2015 May; 10(5):1234-8. PubMed ID: 25723375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Studies of the Kinase Domains of Class IV Lanthipeptide Synthetases.
    Hegemann JD; Shi L; Gross ML; van der Donk WA
    ACS Chem Biol; 2019 Jul; 14(7):1583-1592. PubMed ID: 31243957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roseocin, a novel two-component lantibiotic from an actinomycete.
    Singh M; Chaudhary S; Sareen D
    Mol Microbiol; 2020 Feb; 113(2):326-337. PubMed ID: 31696567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distributive and directional behavior of lantibiotic synthetases revealed by high-resolution tandem mass spectrometry.
    Lee MV; Ihnken LA; You YO; McClerren AL; van der Donk WA; Kelleher NL
    J Am Chem Soc; 2009 Sep; 131(34):12258-64. PubMed ID: 19663480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
    Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
    J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.